摘要
乙型肝炎是威胁全球的健康问题,每年约有60万人死于HBV感染所致的各种疾病,如肝炎、肝硬化和原发性肝癌等。乙型肝炎相关性慢加急性肝衰竭是我国肝衰竭主要类型,在治疗上除综合治疗外,是否进行抗病毒治疗是近年研究的热点。本文就该领域的研究现状作一综述。
Hepatitis B virus is a major public health problem in the world.Every year,about 0.6 million people die of various diseases of HBV infection such as hepatitis,cirrhosis and hepatocellular carcinoma and so on.HBV related acute-on-chronic liver failure is the main type of liver failures in China.Whether or not antiviral therapy on the basis of comprehensive treatment has become a hot topic of recent research in the treatment of fulminant hepatitis B.This article summarizes recent advances in the treatment of HBV related liver failure with nucleoside analogues.
出处
《临床肝胆病杂志》
CAS
2012年第5期391-394,共4页
Journal of Clinical Hepatology
